Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy

Treatment of patients with newly diagnosed primary CNS lymphomas using high dose methotrexate regimens is reported to yield about 30% long term survivors with minimal neurotoxicity. As in other systemic large cell lymphomas, it is generally assumed that most relapses occur within 5 years of diagnosi...

Full description

Saved in:
Bibliographic Details
Published in:CNS Oncol
Main Authors: Ambady, Prakash, Holdhoff, Matthias, Bonekamp, David, Wong, Fay, Grossman, Stuart A
Format: Artigo
Language:Inglês
Published: Future Medicine Ltd 2015
Subjects:
Case Series
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834699/
https://ncbi.nlm.nih.gov/pubmed/26507609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.34
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items